a month ago
ARM
AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Analyst Ranking
Bottom 20%
#4275 out of 5296 analysts
Average Return
-0.16%
Win Rate
46%18 out of 39
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-16 - 2021-03-17 | Buy |
Syndax Pharmaceuticals IncSNDX | +98.15% | $9.21 | $18.25 | 2025-07-14 - 2026-06-12 | Strong Buy |
Cullinan Therapeutics IncCGEM | +86.22% | $7.91 | $14.73 | 2025-05-11 - 2026-05-11 | Strong Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-23 - 2025-09-30 | Strong Buy |
Arm Holdings PLCARM | +77.02% | $215.12 | $380.81 | 2026-05-17 - 2026-06-12 | Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
3 months ago
ASML
5 months ago
ASML
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | 1 | Strong Buy | $45.00 | +43.91% | Maintains | 5 days ago |
Nuvalent IncNUVL | 4 | Hold | $124.00 | +0.61% | Downgrades | 5 days ago |
Biontech SeBNTX | 2 | Strong Buy | $135.00 | +49.11% | Upgrades | 19 days ago |
Arm Holdings PLCARM | 1 | Buy | $300.00 | -21.22% | Initiates Coverage On | a month ago |
Syndax Pharmaceuticals IncSNDX | 4 | Strong Buy | $37.00 | +102.74% | Maintains | a month ago |
Janux Therapeutics IncJANX | 2 | Hold | $15.00 | +10.62% | Downgrades | 2 months ago |
Asml Holding NvASML | 3 | Buy | $1,971.00 | +5.77% | Maintains | 3 months ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $1.50 | +227.51% | Assumes | 3 months ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $8.00 | +171.19% | Maintains | 3 months ago |
Sony Group CorpSONY | 2 | Hold | $22.00 | +7.16% | Downgrades | 3 months ago |
Kura Oncology IncKURA | 4 | Strong Buy | $15.00 | +65.75% | Maintains | 3 months ago |
Iovance Biotherapeutics IncIOVA | 3 | Hold | $4.00 | -1.96% | Maintains | 3 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $128.00 | +48.48% | Maintains | 3 months ago |
Merus NvMRUS | 2 | Hold | $97.00 | +7.78% | Downgrades | 9 months ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | +109.21% | Maintains | 9 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +53.39% | Maintains | a year ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +114.13% | Initiates Coverage On | a year ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | N/A | Maintains | a year ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Adicet Bio IncACET | 1 | Buy | $448.00 | N/A | Initiates Coverage On | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.